Literature DB >> 17596181

A cyclic peptide that binds p75(NTR) protects neurones from beta amyloid (1-40)-induced cell death.

M Yaar1, S Zhai, I Panova, R E Fine, P B Eisenhauer, J K Blusztajn, I Lopez-Coviella, B A Gilchrest.   

Abstract

The current study determined the ability of a p75(NTR) antagonistic cyclic peptide to rescue cells from beta amyloid (Abeta) (1-40)-induced death. p75(NTR)-, p140(trkA)-NIH-3T3 cells or E17 foetal rat cortical neurones were incubated with 125I-NGF or 125I-Abeta (1-40) and increasing concentrations of the cyclic peptide (CATDIKGAEC). Peptide ability to displace 125I-NGF or 125I-Abeta (1-40) binding was determined. Duplicate cultures were preincubated with CATDIKGAEC (250 nM) or diluent and then stimulated with Abeta (1-40). Peptide ability to displace Abeta (1-40) binding, interfere with Abeta (1-40)-induced signalling and rescue cells from Abeta-mediated toxicity was determined by immunoprecipitation and autoradiography, Northern blotting, JNK activation, MTT and trypan blue assays. The peptide inhibited NGF and Abeta (1-40) binding to p75(NTR), but not to p140(trkA). Abeta (1-40) induced c-jun transcription (57.3% +/- 0.07%) in diluent-treated p75(NTR)-cells, but not in cells preincubated with the cyclic peptide. Also, at 250 nM, the peptide reduced Abeta (1-40)-induced phosphorylation of JNK by 71.8% +/- 0.03% and protected neurones against Abeta-induced toxicity as determined by: trypan blue exclusion assay (53% +/- 11% trypan blue-positive cells in diluent pretreated cultures vs. 28% +/- 5% in cyclic peptide-pretreated cultures); MTT assay (0.09 +/-0.03 units in diluent-pretreated cells vs. 0.12 +/- 0.004 units in cyclic peptide-pretreated cells); and visualization of representative microscopic fields. Our data suggest that a cyclic peptide homologous to amino acids 28-36 of NGF known to mediate binding to p75(NTR) can interfere with Abeta (1-40) signalling and rescue neurones from Abeta (1-40)-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596181     DOI: 10.1111/j.1365-2990.2007.00844.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  13 in total

Review 1.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation.

Authors:  Mina Yaar; Bennet L Arble; Kenneth B Stewart; Nazer H Qureshi; Neil W Kowall; Barbara A Gilchrest
Journal:  Cell Mol Neurobiol       Date:  2008-09-19       Impact factor: 5.046

3.  TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor.

Authors:  Thangiah Geetha; Chen Zheng; Wade C McGregor; B Douglas White; Maria T Diaz-Meco; Jorge Moscat; Jeganathan Ramesh Babu
Journal:  Neurochem Int       Date:  2012-09-24       Impact factor: 3.921

4.  Role of amyloid β protein receptors in mediating synaptic plasticity.

Authors:  Yu Li; Zhongqing Sun; Qiaoyu Cao; Meiwan Chen; Huanmin Luo; Xi Lin; Fei Xiao
Journal:  Biomed Rep       Date:  2017-02-21

5.  The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.

Authors:  Juliet K Knowles; Jayakumar Rajadas; Thuy-Vi V Nguyen; Tao Yang; Melburne C LeMieux; Lilith Vander Griend; Chihiro Ishikawa; Stephen M Massa; Tony Wyss-Coray; Frank M Longo
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

Review 6.  Signaling effect of amyloid-beta(42) on the processing of AbetaPP.

Authors:  Massimo Tabaton; Xiongwei Zhu; George Perry; Mark A Smith; Luca Giliberto
Journal:  Exp Neurol       Date:  2009-09-09       Impact factor: 5.330

7.  Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction.

Authors:  Joanna Fombonne; Shahrooz Rabizadeh; Surita Banwait; Patrick Mehlen; Dale E Bredesen
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

Review 8.  Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

Review 9.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment.

Authors:  Tao Yang; Juliet K Knowles; Qun Lu; Hong Zhang; Ottavio Arancio; Laura A Moore; Timothy Chang; Qian Wang; Katrin Andreasson; Jayakumar Rajadas; Gerald G Fuller; Youmei Xie; Stephen M Massa; Frank M Longo
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.